1. From the BHF Cardiovascular Research Centre (J.J.V.M.) and Department of Public Health and Health Policy (J.L.), University of Glasgow, Glasgow, Scotland, United Kingdom; University of Michigan School of Medicine (B.P.), Ann Arbor, Mich; Department of Cardiovascular Research (R.L.), Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; ANMCO Research Center (A.P.M.), Florence, Italy; Brigham & Women’s Hospital (S.D.S., A.V.), Boston, Mass; and Novartis Pharmaceuticals Corporation (D.L.K...